Dr. Vladimir Misik

PhD in Biophysical Pharmacology, MSc. Solid-state physics
>30 years in biopharmaceutical research and development
Research cardiovascular pharmacology, and oncology
Slovak Academy of Sciences, Bratislava, Slovakia
The George Washington University Medical School, Washington DC, USA
National Cancer Institute at NIH, Bethesda, MD, USA
Product development/CRO QuintilesIMS
Head of global operations center (GDN), India
Regional head of CEE and MENA clinical operations
Head of Business development fir CEE and MENA
Currently: LongTaal sro, Founder & Managing Partner www.longtaal.com
Subscription-based CT informatics portal, customized reports and market trend analyses utilized by policy advocates, senior managers pharmaceutical companies and CROs, presented at international conferences, and published in peer-reviewed journals

> 60 research articles and book chapters in peer-reviewed journals, including several recent publications on globalization of clinical trials:
co-author of Clinical Trials in the Middle East and North Africa (in Global Clinical Trials, Elsevier 2011, eds. R Chin, M. Bairu))
V Misik, Shifting Sands: Global Clinical Trials: MENA Region, European Pharmaceutical Contractor, September 2011, pp 66-70
V Misik, Expected Growth of Industry-Sponsored Clinical Trials in the Middle East Benchmarked on other Global Regions, Quintiles White Paper, February 2012, pp 1-12
V Misik, Room to Bloom in MENA, Emerging Markets: MENA, SCRIP, April 2012, pp 20-22
V Misik,, RV Brady, M Bolecek and H Klech, Current Trends in Globalization of Industry-Sponsored Clinical Trials, Applied Clinical Research, Clinical Trials & Regulatory Affairs, 2014, 1, 56-66